The North American intraoperative imaging market is estimated to reach $1.09 billion by 2019, according to a report by market research firm MicroMarket Monitor.
The market is expected to grow at a compound annual growth rate (CAGR) of 1.8% between 2014 and 2019. Intraoperative imaging includes real-time imaging modalities such as CT, MRI, and ultrasound that are used during surgical procedures to provide real-time images of the operation. The images help surgeons with decision-making throughout surgery, such as the precise placement of implants and complete tumor removal.
Intraoperative CT commanded the largest portion of the North American intraoperative imaging market. It is used for the removal of deep-seated tumors such as glioblastomas, second-grade and third-grade astrocytomas, oligodendrogliomas, olfactory groove meningiomas, melanomas, and arteriovenous malformations.
Recent clearances of intraoperative systems by the U.S. Food and Drug Administration (FDA) are expected to have a positive influence on the growth of the market, the firm said.
To access the report, click here.
